SCHEMBL7493280

SCHEMBL7493280

CSc1ccc(F)cc1C(=O)CBr

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 2/20 0.46
▸ LMNA P02545 1/20 0.41
▸ CES2 O00748 2/20 0.39
▸ CES1 P23141 2/20 0.39
▸ DDR1 Q08345 1/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ GSK3B P49841 1/20 0.34
▸ AR P10275 1/20 0.34
▸ HPGDS O60760 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ AGBL2 Q5U5Z8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7500560 0.82 LMNA (0.40) LMNACES2CES1DDR1KEAP1
SCHEMBL7493689 0.81 GSK3B (0.44) PTPN1CES2MAPTRAB9AKMT2A
SCHEMBL7493802 0.80 GSK3B (0.46) LMNAMEN1MAPTKMT2AGSK3B
SCHEMBL11771246 0.79 KEAP1 (0.53) LMNACES2CES1DDR1KEAP1
SCHEMBL7494317 0.79 CES2 (0.44) LMNACES2CES1DDR1KEAP1
SCHEMBL3924529 0.77 PTPN1 (0.50) PTPN1CES2CES1KEAP1MEN1
SCHEMBL7496107 0.77 HPGD (0.40) LMNACES2CES1DDR1MEN1
SCHEMBL2099037 0.77 CES2 (0.61) PTPN1CES2CES1KEAP1MEN1
SCHEMBL3230200 0.75 PTPN1 (0.52) PTPN1LMNACES2CES1KEAP1
SCHEMBL18797551 0.75 PTPN1 (0.52) PTPN1LMNACES2CES1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100803-B1 PYRROLO [2,1-B] [1,3]BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA TAU IND FARMACEUTI (IT) 2002-10-02 — — EP disclosed
US-6391870-B2 DOPAMINERGIC AGENT SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2002-05-21 — — US disclosed
US-20020006921-A1 Pyrrolo {2,1-b}{1,3}benzothiazepines with atypical antipsychotic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2002-01-17 — — US disclosed
EP-1100803-A2 PYRROLO 2,1-B] 1,3]BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2001-05-23 — — EP disclosed
WO-2000006579-A2 PYRROLO[2,1-B][1,3]BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2000-02-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006921-A1 Pyrrolo {2,1-b}{1,3}benzothiazepines with atypical antipsychotic activity GABRE, GRIN2B, DRD1 PTPN1 2189/4885LMNA 4553/4885CES2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback